IL13 and urethra adenocarcinoma: Type 2 (T2) inflammation, mediated by cytokines such as IL-4, IL-5, and IL-13, and effector cells including eosinophils and ILC2s, represents a central pathogenic mechanism across many UAD phenotypes.